Seeking a Makeover, Boston Life Sciences (BLSI) Changes Its Name
9/3/2007 11:10:27 PM
More...
|
Boston Life Sciences (BLSI) Changes Name to ALSERES Pharmaceuticals, Inc. (ALSE)
6/8/2007 12:56:25 PM
More...
|
Boston Life Sciences (BLSI) Announces Webcast of 2007 Annual Meeting
6/6/2007 12:16:00 PM
More...
|
Boston Life Sciences (BLSI) Names Scientific and Clinical Advisors for Nerve Repair Program
5/29/2007 2:31:26 PM
More...
|
Boston Life Sciences (BLSI) to Host 2007 1st Quarter Conference Call
5/9/2007 2:44:35 PM
More...
|
Boston Life Sciences (BLSI) Raises $6 Million Through Issuance of a Convertible Promissory Note to a New Fund
5/3/2007 11:46:25 AM
More...
|
Boston Life Sciences (BLSI) to Present at the 2007 Biotechnology Industry Organization (BIO) Annual BIO International Convention
5/1/2007 11:44:31 AM
More...
|
Boston Life Sciences (BLSI) Reports New Option Grants Under NASDAQ Market Rule 4350
4/17/2007 1:06:22 PM
More...
|
Boston Life Sciences (BLSI) Announces Presentation of Cethrin(R) Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
4/16/2007 1:19:19 PM
More...
|
Boston Life Sciences (BLSI) Appoints Frank Bobe as Executive Vice President and Chief Business Officer
4/16/2007 11:03:12 AM
More...
|
|